Profectus BioSciences' Unattributed VC Round

Profectus BioSciences raised a round of funding on May 15, 2006. Investors include Cross Atlantic Capital Partners.

Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, mean…

Articles about Profectus BioSciences' Unattributed VC Round: